| P2093 | author name string | Allyson Kayton | |
| | Paula Timoney | |
| | Jose A Perez | |
| | Lyn Vargo | |
| P2860 | cites work | Restricted versus liberal oxygen exposure for preventing morbidity and mortality in preterm or low birth weight infants | Q24241782 |
| | Safe oxygen saturation targeting and monitoring in preterm infants: can we avoid hypoxia and hyperoxia? | Q24289151 |
| | Optimum oxygen therapy in preterm babies | Q24652401 |
| | Oxygen saturation target range for extremely preterm infants: a systematic review and meta-analysis | Q26863718 |
| | Gene-environment interactions in severe intraventricular hemorrhage of preterm neonates | Q26996782 |
| | Neonatal Resuscitation: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care | Q30054393 |
| | Target ranges of oxygen saturation in extremely preterm infants | Q30434084 |
| | Avoiding hyperoxia in infants 1250 g is associated with improved short- and long-term outcomes | Q30463931 |
| | Oxygen saturation monitoring for the preterm infant: the evidence basis for current practice | Q30476532 |
| | Can Changes in Clinical Practice Decrease the Incidence of Severe Retinopathy of Prematurity in Very Low Birth Weight Infants? | Q30477134 |
| | Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study): a double-blind, randomised controlled trial | Q33156379 |
| | Prenatal and Neonatal Risk Factors for Childhood Lymphatic Leukemia | Q72038592 |
| | Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure | Q73080410 |
| | Changes in the lungs of the new-born lamb | Q73260990 |
| | Improvement of oxygenation induced by aerosolized prostacyclin in a preterm infant with persistent pulmonary hypertension of the newborn | Q74198658 |
| | Inhaled nitric oxide for the early treatment of persistent pulmonary hypertension of the term newborn: a randomized, double-masked, placebo-controlled, dose-response, multicenter study. The I-NO/PPHN Study Group | Q74238242 |
| | Supplementary oxygen and risk of childhood lymphatic leukaemia | Q78958898 |
| | Oxygen therapy in preterm infants: hitting the target | Q79174075 |
| | Childhood cancer following neonatal oxygen supplementation | Q80389754 |
| | Pulse oxygen saturation levels and arterial oxygen tension values in newborns receiving oxygen therapy in the neonatal intensive care unit: is 85% to 93% an acceptable range? | Q81198598 |
| | A randomized, double-blind, placebo-controlled, prospective study of bosentan for the treatment of persistent pulmonary hypertension of the newborn | Q82467983 |
| | Oxygen and retinopathy of prematurity | Q82790444 |
| | Oxygen therapy in the neonatal care environment | Q84478564 |
| | Patterns of respiratory disease during the first 2 postnatal weeks in extremely premature infants | Q33779580 |
| | Long term consequences of oxygen therapy in the neonatal period | Q34020760 |
| | Neurodevelopmental outcomes in the early CPAP and pulse oximetry trial | Q34075235 |
| | Retinopathy of prematurity and pulse oximetry: a national survey of recent practices | Q34546090 |
| | Optimal oxygenation of extremely low birth weight infants: a meta-analysis and systematic review of the oxygen saturation target studies | Q34657573 |
| | Pulmonary hemodynamics and vascular reactivity in asphyxiated term lambs resuscitated with 21 and 100% oxygen | Q35562030 |
| | Free radicals and diseases in premature infants | Q35624550 |
| | A physiologic reduced oxygen protocol decreases the incidence of threshold retinopathy of prematurity | Q35662624 |
| | Pulmonary arterial contractility in neonatal lambs increases with 100% oxygen resuscitation | Q36169607 |
| | The pulmonary circulation in neonatal respiratory failure | Q36687766 |
| | Oxygen, the lead actor in the pathophysiologic drama: enactment of the trinity of normoxia, hypoxia, and hyperoxia in disease and therapy | Q36932714 |
| | Signal transduction pathways involved in oxidative stress-induced intestinal epithelial cell apoptosis | Q37123639 |
| | Clinical practices in neonatal oxygenation: where have we failed? What can we do? | Q37150754 |
| | Resuscitation of newborn infants with 21% or 100% oxygen: an updated systematic review and meta-analysis | Q37210840 |
| | Oxygen in health and disease: regulation of oxygen homeostasis--clinical implications | Q37293099 |
| | Why are we still using oxygen to resuscitate term infants? | Q37793848 |
| | Hyperoxia in very preterm infants: a systematic review of the literature | Q37913871 |
| | Oxygen: the poison is in the dose | Q38026923 |
| | Effects of targeting higher vs lower arterial oxygen saturations on death or disability in extremely preterm infants: a randomized clinical trial | Q38452031 |
| | Part 13: Neonatal Resuscitation: 2015 American Heart Association Guidelines Update for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care | Q38608803 |
| | Initiating delivery room stabilization/resuscitation in very low birth weight (VLBW) infants with an FiO(2) less than 100% is feasible | Q39478178 |
| | Outcomes of Two Trials of Oxygen-Saturation Targets in Preterm Infants | Q40918503 |
| | Aerosolised prostacyclin for pulmonary hypertension in neonates | Q41782898 |
| | Oxidative-nitrosative stress in a rabbit pup model of germinal matrix hemorrhage: role of NAD(P)H oxidase | Q41810956 |
| | Light microscopic and ultrastructural study of the adverse effects of oxygen therapy on the neonate lung | Q42150970 |
| | Diagnosis and treatment of pulmonary hypertension in infancy | Q42508912 |
| | Pharmacology of milrinone in neonates with persistent pulmonary hypertension of the newborn and suboptimal response to inhaled nitric oxide | Q42675529 |
| | Superoxide dismutase restores eNOS expression and function in resistance pulmonary arteries from neonatal lambs with persistent pulmonary hypertension | Q43226235 |
| | Intravenous sildenafil in the treatment of neonates with persistent pulmonary hypertension | Q43260002 |
| | Inhaled prostacyclin for term infants with persistent pulmonary hypertension refractory to inhaled nitric oxide. | Q44235977 |
| | Combination of bosentan with epoprostenol in pulmonary arterial hypertension: BREATHE-2. | Q45052802 |
| | Oxygen saturation and outcomes in preterm infants | Q45349113 |
| | Room-air resuscitation causes less damage to heart and kidney than 100% oxygen | Q46686120 |
| | Can inhaled prostacyclin stimulate surfactant in ELBW infants? | Q46932382 |
| | Reduction in the incidence of chronic lung disease in very low birth weight infants: results of a quality improvement process in a tertiary level neonatal intensive care unit | Q47201222 |
| | Nitrosative and oxidative injury to premyelinating oligodendrocytes in periventricular leukomalacia | Q47884238 |
| | Randomized controlled trial of oxygen saturation targets in very preterm infants: two year outcomes | Q50425987 |
| | Oxygen-saturation targets and outcomes in extremely preterm infants. | Q52100740 |
| | Radiographic features of pulmonary oxygen toxicity in the newborn: Bronchopulmonary dysplasia. | Q54046393 |
| | The changes in the circulation after birth. Their importance in congenital heart disease. | Q54681756 |
| | Oral Sildenafil in Infants With Persistent Pulmonary Hypertension of the Newborn: A Pilot Randomized Blinded Study | Q56636803 |
| | Low-Dose Nitric Oxide Therapy for Persistent Pulmonary Hypertension of the Newborn | Q60146859 |
| | Role of endothelium-derived relaxing factor during transition of pulmonary circulation at birth | Q68635283 |
| P275 | copyright license | Creative Commons Attribution-NonCommercial-NoDerivatives | Q6937225 |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | oxygen | Q629 |
| | inorganic compound | Q190065 |
| | vasodilator agent | Q4008956 |
| P304 | page(s) | 98-104 | |
| P577 | publication date | 2018-04-01 | |
| P1433 | published in | Advances in Neonatal Care | Q4686388 |
| P1476 | title | A Review of Oxygen Physiology and Appropriate Management of Oxygen Levels in Premature Neonates | |
| P478 | volume | 18 | |